Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

In recent years, more and more medics have used their platforms to spread awareness about the concerning surge of colon ...

Lilly and Novo Nordisk are hoping to win over employers on the idea that obesity and its complications are already a huge cost in terms of healthcare, workers' compensation and disability. By offering ...

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention, and more than half a million Americans have a stroke every year. But up ...

Dr Eric Berg DC is a ketosis and intermittent fasting expert, and he has shared the many benefits of turmeric, as well as how ...

According to experts, Generation Z and Millennials are doing one thing that might be contributing to the rise in colon cancer ...

Here are 10 very healthy and low calorie foods that you can munch on if you have nighttime hypoglycemia or diabetes. Look out ...

Novo Nordisk launches its weight-loss drug Wegovy in China after approval by local health authorities in June.

What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which play a major role in your weight and weight loss, says Dr. Russo. These ...

Danish pharmaceutical company Novo Nordisk announced last weekend that Wegovy, the weight-loss version of the company's ...